Saxenda, Victoza, and Trulicity still matter It is easy for older medications to get overlooked in a conversation dominated by semaglutide and tirzepatide, but Saxenda, Victoza, and Trulicity still have an important place in care
Kudaravalli S, den Hollander P, Mani SA
Special Senses: abnormal vision, conjunctivitis, diplopia, eye pain, tinnitus
Preparing your benefit design for the expanding GLP-1 pipeline These questions matter now
Better known to the public by brand names such as Ozempic, Wegovy, Trulicity, Rybelsus, Victoza, Saxenda, and Mounjaro, these glucose-lowering medications, which were initially approved for the treatment of patients with type 2 diabetes, have made headlines recently thanks to their demonstrated effectiveness at treating obesity and helping people with or without diabetes lose weight
Recent reports suggest that GLP-1 drugs could have a significant economic impact in 2025